Appellate Court Upholds Injunction Against PTO Final Rule

A federal court has upheld an injunction of a PTO final rule that would have affected generic-drug makers by changing the number of claims allowed for patent applications by innovator companies and the number of continuing applications such companies could file. The U.S. Court of Appeals for the Federal Circuit dismissed the case at the request of the PTO and GlaxoSmithKline after the PTO announced it would rescind the rule.
Generic Line